Can Healthcare Stocks Keep Outperforming the Market?

Karen Anderson, director of healthcare equity research for Morningstar Research Services, discusses the forces shaping the landscape and where she sees opportunities for investors.   Key Takeaways: Why Healthcare Stocks Have Been Resilient During the Market Downturn How Regulatory Changes Could Affect the Healthcare Industry Why Healthcare Stocks’ Valuations Look Attractive From a Bottom-Up View How Have Healthcare Stocks’ Valuations Changed Historically? How Stock Valuations Differ Within the Healthcare Sector   How an Aging US Population Affects the Healthcare Sector   Will GLP-1 Drugs Continue to Grow?   Regulatory Risks for Healthcare Stocks   Healthcare Stocks Outlook   Are Healthcare Stocks a Buy?   Healthcare Stock Picks   How Amgen Is Using AI in Healthcare     Read about topics from this episode.   Healthcare: Sector Looks Undervalued with Pullback After US Election and Obesity Data Novo Nordisk: Next-Generation GLP-1/Amylin Drug Sees Leading Weight Loss in Small Trial How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks Biopharma Stock Election Impact: Potential Reduced IRA Headwind but Unpredictable Challenges 22 Best Healthcare Companies to Invest In     What to watch from Morningstar. Worried About a Market Sell-Off? These 10 Funds Reduce Portfolio Risk  Gray Divorce: How to Avoid Triggering a Costly Tax Bill Why the Bond Market Looks Brighter Than It Did in 2022 Where to Find Bargain Stocks in an Expensive Market     Read what our team is writing: Karen Andersen Sarah Hansen   Follow us on social media. Facebook: https://www.facebook.com/MorningstarInc/ X: https://x.com/MorningstarInc Instagram: https://www.instagram.com/morningstar...  LinkedIn: https://www.linkedin.com/company/5161/